CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2021; 25(03): e374-e378
DOI: 10.1055/s-0040-1715152
Original Research

Alternative Inverted Middle Fossa Approach in Bonebridge Surgery. Technique, Results and Complications

1   Department of ENT, Universidad Nacional de Cordoba, Sanatorio Allende, Cordoba, Córdoba, Argentina
2   Department of Otorhinolaringology, Universidad Nacional de Cordoba, Cordoba, Córdoba, Argentina
3   Department of Otorhinolaringology, Universidad Católica de Cordoba, Cordoba, Córdoba, Argentina
,
1   Department of ENT, Universidad Nacional de Cordoba, Sanatorio Allende, Cordoba, Córdoba, Argentina
,
1   Department of ENT, Universidad Nacional de Cordoba, Sanatorio Allende, Cordoba, Córdoba, Argentina
› Author Affiliations

Abstract

Introduction The transmastoid approach is the most recommended technique to Bonebridge surgery, while in patients with bad anatomy or in the canal wall down technique, retrosigmoid or Middle Fossa Approaches are the alternative surgical options.

Objective To describe a novel alternative approach called inverted middle fossa approach (IMFA) and its technique and audiological outcomes.

Methods Seven patients submitted to the IMFA were included. All patients presented conductive and mixed hearing loss with bone thresholds of the audiogram > 40 dB. The audiological test was conducted pre- and postoperatively.

Results A total of 5 males and 2 females, aged 13,8 years old (range 6–25 years old) were studied. The average follow-up was of 20 months (12 to 32 months). All patients presented aural atresia, except one with severe osseous-fibrous dysplasia of the temporal bone. Two patients showed bilateral compromise, three patients had associated Goldenhar and Treacher Collins syndrome. On the preoperative audiograms, air conduction (AC) thresholds showed a PTA4 (0.5, 1, 2 and 4 kHz) of 66.7 dB (standard deviation [SD] =  ± 7.8), while the bone conduction thresholds reached an average of 11.2 dB (SD =  ± 6.9). The postoperative thresholds did not change, and additional sensorineural damage was not observed before activation. Four weeks after surgery, all the patients were fitted with the external processor. The postoperative audiological aided exam showed AC PTA 4 thresholds of 18.9 dB (SD =  ± 5.9).

Conclusion The IMFA allows the nearest position of the microphone to the external auditory canal. The technique is a suitable option to the 3 classical approaches with similar rate of audiological results. More investigation is needed to determine the benefit of the novel approach compared with the others.



Publication History

Received: 03 May 2020

Accepted: 24 June 2020

Article published online:
24 September 2020

© 2020. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Gavilan J, Adunka O, Agrawal S. et al. Quality standards for bone conduction implants. Acta Otolaryngol 2015; 135 (12) 1277-1285
  • 2 Zernotti ME, Curet CA, Cortasa S, Chiaraviglio M, Di Gregorio MF. Congenital Aural Atresia prevalence in the Argentinian population. Acta Otorrinolaringol Esp 2019; 70 (01) 32-35
  • 3 Zernotti ME, Sarasty AB. Active Bone Conduction Prosthesis: Bonebridge(TM). Int Arch Otorhinolaryngol 2015; 19 (04) 343-348
  • 4 Zernotti ME, Chiaraviglio MM, Mauricio SB, Tabernero PA, Zernotti M, Di Gregorio MF. Audiological outcomes in patients with congenital aural atresia implanted with transcutaneous active bone conduction hearing implant. Int J Pediatr Otorhinolaryngol 2019; 119: 54-58
  • 5 Lassaletta L, Sanchez-Cuadrado I, Muñoz E, Gavilan J. Retrosigmoid implantation of an active bone conduction stimulator in a patient with chronic otitis media. Auris Nasus Larynx 2014; 41 (01) 84-87
  • 6 Siegel L, You P, Zimmerman K, Parnes L, Agrawal SK. Active Transcutaneous Bone Conduction Implant: Audiometric Outcomes Following a Novel Middle Fossa Approach With Self-Drilling Screws. Otol Neurotol 2020; 41 (05) 605-613
  • 7 Bravo-Torres S, Der-Mussa C, Fuentes-López E. Active transcutaneous bone conduction implant: audiological results in paediatric patients with bilateral microtia associated with external auditory canal atresia. Int J Audiol 2018; 57 (01) 53-60
  • 8 Der C, Bravo-Torres S, Pons N. Active Transcutaneous Bone Conduction Implant: Middle Fossa Placement Technique in Children With Bilateral Microtia and External Auditory Canal Atresia. Otol Neurotol 2018; 39 (05) e342-e348
  • 9 Baumgartner WD, Hamzavi JS, Böheim K. et al. A New Transcutaneous Bone Conduction Hearing Implant: Short-term Safety and Efficacy in Children. Otol Neurotol 2016; 37 (06) 713-720
  • 10 Magele A, Schoerg P, Stanek B, Gradl B, Sprinzl GM. Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis. PLoS One 2019; 14 (09) e0221484 Doi: 10.1371/journal.pone.0221484
  • 11 Lassaletta L, Calvino M, Zernotti M, Gavilán J. Postoperative pain in patients undergoing a transcutaneous active bone conduction implant (Bonebridge). Eur Arch Otorhinolaryngol 2016; 273 (12) 4103-4110
  • 12 Sprinzl GM, Wolf-Magele A. The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature. Clin Otolaryngol 2016; 41 (02) 131-143 Doi: 10.1111/coa.12484